Veris Health Awarded $1.8 Million NIH Grant to Advance Cancer Care Innovations
**Veris Health Awarded $1.8 Million NIH Grant to Advance Cancer Care Innovations**
*October 2023* — Veris Health, a leading digital health company specializing in oncology care, has been awarded a $1.8 million grant from the National Institutes of Health (NIH) to further its efforts in advancing cancer care innovations. This grant, part of the NIH’s Small Business Innovation Research (SBIR) program, will support Veris Health’s ongoing development of cutting-edge technologies aimed at improving the quality of life and clinical outcomes for cancer patients.
### Veris Health: A Pioneer in Digital Oncology
Veris Health is at the forefront of integrating digital health solutions with oncology care. The company’s mission is to leverage technology to enhance the precision and personalization of cancer treatment, while also improving patient monitoring and engagement. Veris Health’s platform combines real-time data collection with advanced analytics to provide oncologists with actionable insights, enabling more informed decision-making in cancer care.
The company’s flagship product is a remote patient monitoring (RPM) platform designed specifically for oncology patients. This platform allows for continuous tracking of vital signs, symptoms, and treatment responses, providing oncologists with a comprehensive view of a patient’s health status between clinical visits. By capturing real-time data, Veris Health aims to detect potential complications early, reduce hospitalizations, and optimize treatment plans.
### NIH Grant: Fueling Innovation in Cancer Care
The $1.8 million NIH grant will be instrumental in accelerating Veris Health’s research and development efforts. Specifically, the funding will be used to enhance the company’s remote monitoring platform and expand its capabilities to include predictive analytics and machine learning algorithms. These advancements are expected to significantly improve the early detection of adverse events, such as treatment-related toxicities, and allow for timely interventions.
The NIH’s SBIR program is designed to support small businesses engaged in innovative research with the potential for commercialization. Veris Health’s receipt of this grant underscores the NIH’s recognition of the company’s potential to make a meaningful impact on cancer care through its technology-driven approach.
### Addressing Critical Challenges in Oncology
Cancer care is often complex, involving multiple treatment modalities such as chemotherapy, radiation, immunotherapy, and surgery. Patients undergoing these treatments frequently experience side effects that can range from mild to life-threatening. Traditional models of care rely heavily on in-person visits, which may not always capture the full scope of a patient’s experience between appointments.
Veris Health’s remote monitoring platform addresses this gap by providing oncologists with continuous access to patient data. This allows for the early identification of issues such as dehydration, infection, or treatment-related toxicities, which can be managed more effectively when detected early. Moreover, the platform’s ability to track patient-reported outcomes, such as pain levels and fatigue, enables a more holistic approach to care.
### The Role of Predictive Analytics and Machine Learning
One of the key areas of focus for Veris Health, supported by the NIH grant, is the integration of predictive analytics and machine learning into its platform. By analyzing large datasets from cancer patients, these technologies can identify patterns and trends that may not be immediately apparent to clinicians. For example, machine learning algorithms can predict which patients are at higher risk for complications based on their individual health data, allowing for more proactive management.
Predictive analytics can also help optimize treatment plans by identifying the most effective therapies for specific patient populations. As cancer treatment becomes increasingly personalized, the ability to tailor interventions to the unique needs of each patient is critical. Veris Health’s platform aims to provide oncologists with the tools they need to deliver more precise, data-driven care.
### Enhancing Patient Engagement and Quality of Life
In addition to improving clinical outcomes, Veris Health’s technology is designed to enhance patient engagement. The platform includes a user-friendly mobile app that allows patients to easily report symptoms, track their progress, and communicate with their care team. By empowering patients to take a more active role in their care, Veris Health aims to improve adherence to treatment plans and overall quality of life.
Cancer patients often face significant physical, emotional, and financial challenges during their treatment journey. Veris Health’s platform seeks to alleviate some of these burdens by providing patients with the tools and support they need to manage their health more effectively. The ability to monitor symptoms in real-time and receive timely interventions can reduce the need for emergency room visits and hospitalizations, ultimately lowering healthcare costs and improving patient satisfaction.
### Looking Ahead: The Future of Cancer Care
The NIH grant represents a significant milestone for Veris Health as it continues to push the boundaries of what is possible in cancer care. With the support of this funding, the company is well-positioned to advance its technology and bring its innovative solutions to a broader patient population.
As the healthcare industry increasingly embraces digital health solutions, Veris Health’s platform has the potential to transform the way cancer care is delivered. By providing oncologists with real-time data and predictive insights, the company